Global Pharma Ophthalmic Market Growth 2023-2029

Global Pharma Ophthalmic Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Pharma Ophthalmic Industry Forecast” looks at past sales and reviews total world Pharma Ophthalmic sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharma Ophthalmic sales for 2023 through 2029. With Pharma Ophthalmic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma Ophthalmic industry.

This Insight Report provides a comprehensive analysis of the global Pharma Ophthalmic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharma Ophthalmic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pharma Ophthalmic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma Ophthalmic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma Ophthalmic.

The global Pharma Ophthalmic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Pharma Ophthalmic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pharma Ophthalmic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pharma Ophthalmic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pharma Ophthalmic players cover Novartis, Allergan, Roche, Valeant, Regeneron, Santen, Bayer, Pfizer and Senju, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharma Ophthalmic market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Other ophthalmic drugs

Segmentation by application
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharma Ophthalmic market?

What factors are driving Pharma Ophthalmic market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharma Ophthalmic market opportunities vary by end market size?

How does Pharma Ophthalmic break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.